Amass
PrivateLast Round
Seed
Aug 22, 2025
Total Funding Raised
$1.63M
Company Overview
Amass is a software company that provides an AI-powered platform for researchers and biotech teams to unify, search, and summarize scientific papers, patents, and other data sources.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Vertical SaaS, Business Intelligence
Business Model
B2B
Customer Profile
Subscription SaaS, Freemium
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amass Comps
Public and private peers based on sector, stage, and business model.
Amass Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 22, 2025 |
Amass Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kost Capital | Seed |
| Giant Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 12, 2026
Introduced *Core, a new naming framework for its data sources.
- Jan 30, 2026
Amass announced the launch of a set of new, unnamed features designed to provide users with more control over their data and reports.
Amass Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Amass's valuation, stock price, and market status.
